-
Artificial Intelligence and Diabetes Mellitus: An Inside Look Through the Retina
Authors:
Yasin Sadeghi Bazargani,
Majid Mirzaei,
Navid Sobhi,
Mirsaeed Abdollahi,
Ali Jafarizadeh,
Siamak Pedrammehr,
Roohallah Alizadehsani,
Ru San Tan,
Sheikh Mohammed Shariful Islam,
U. Rajendra Acharya
Abstract:
Diabetes mellitus (DM) predisposes patients to vascular complications. Retinal images and vasculature reflect the body's micro- and macrovascular health. They can be used to diagnose DM complications, including diabetic retinopathy (DR), neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as forecast the risk of cardiovascular events. Artificial intelligence (AI)-enabled s…
▽ More
Diabetes mellitus (DM) predisposes patients to vascular complications. Retinal images and vasculature reflect the body's micro- and macrovascular health. They can be used to diagnose DM complications, including diabetic retinopathy (DR), neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as forecast the risk of cardiovascular events. Artificial intelligence (AI)-enabled systems developed for high-throughput detection of DR using digitized retinal images have become clinically adopted. Beyond DR screening, AI integration also holds immense potential to address challenges associated with the holistic care of the patient with DM. In this work, we aim to comprehensively review the literature for studies on AI applications based on retinal images related to DM diagnosis, prognostication, and management. We will describe the findings of holistic AI-assisted diabetes care, including but not limited to DR screening, and discuss barriers to implementing such systems, including issues concerning ethics, data privacy, equitable access, and explainability. With the ability to evaluate the patient's health status vis a vis DM complication as well as risk prognostication of future cardiovascular complications, AI-assisted retinal image analysis has the potential to become a central tool for modern personalized medicine in patients with DM.
△ Less
Submitted 27 February, 2024;
originally announced February 2024.
-
Current and future roles of artificial intelligence in retinopathy of prematurity
Authors:
Ali Jafarizadeh,
Shadi Farabi Maleki,
Parnia Pouya,
Navid Sobhi,
Mirsaeed Abdollahi,
Siamak Pedrammehr,
Chee Peng Lim,
Houshyar Asadi,
Roohallah Alizadehsani,
Ru-San Tan,
Sheikh Mohammad Shariful Islam,
U. Rajendra Acharya
Abstract:
Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. R…
▽ More
Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs), have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential. This research comprehensively examines the contemporary progress and challenges associated with using retinal imaging and artificial intelligence (AI) to detect ROP, offering valuable insights that can guide further investigation in this domain. Based on 89 original studies in this field (out of 1487 studies that were comprehensively reviewed), we concluded that traditional methods for ROP diagnosis suffer from subjectivity and manual analysis, leading to inconsistent clinical decisions. AI holds great promise for improving ROP management. This review explores AI's potential in ROP detection, classification, diagnosis, and prognosis.
△ Less
Submitted 15 February, 2024;
originally announced February 2024.
-
Artificial Intelligence in Assessing Cardiovascular Diseases and Risk Factors via Retinal Fundus Images: A Review of the Last Decade
Authors:
Mirsaeed Abdollahi,
Ali Jafarizadeh,
Amirhosein Ghafouri Asbagh,
Navid Sobhi,
Keysan Pourmoghtader,
Siamak Pedrammehr,
Houshyar Asadi,
Roohallah Alizadehsani,
Ru-San Tan,
U. Rajendra Acharya
Abstract:
Background: Cardiovascular diseases (CVDs) are the leading cause of death globally. The use of artificial intelligence (AI) methods - in particular, deep learning (DL) - has been on the rise lately for the analysis of different CVD-related topics. The use of fundus images and optical coherence tomography angiography (OCTA) in the diagnosis of retinal diseases has also been extensively studied. To…
▽ More
Background: Cardiovascular diseases (CVDs) are the leading cause of death globally. The use of artificial intelligence (AI) methods - in particular, deep learning (DL) - has been on the rise lately for the analysis of different CVD-related topics. The use of fundus images and optical coherence tomography angiography (OCTA) in the diagnosis of retinal diseases has also been extensively studied. To better understand heart function and anticipate changes based on microvascular characteristics and function, researchers are currently exploring the integration of AI with non-invasive retinal scanning. There is great potential to reduce the number of cardiovascular events and the financial strain on healthcare systems by utilizing AI-assisted early detection and prediction of cardiovascular diseases on a large scale. Method: A comprehensive search was conducted across various databases, including PubMed, Medline, Google Scholar, Scopus, Web of Sciences, IEEE Xplore, and ACM Digital Library, using specific keywords related to cardiovascular diseases and artificial intelligence. Results: The study included 87 English-language publications selected for relevance, and additional references were considered. This paper provides an overview of the recent developments and difficulties in using artificial intelligence and retinal imaging to diagnose cardiovascular diseases. It provides insights for further exploration in this field. Conclusion: Researchers are trying to develop precise disease prognosis patterns in response to the aging population and the growing global burden of CVD. AI and deep learning are revolutionizing healthcare by potentially diagnosing multiple CVDs from a single retinal image. However, swifter adoption of these technologies in healthcare systems is required.
△ Less
Submitted 28 April, 2024; v1 submitted 11 November, 2023;
originally announced November 2023.
